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Abstract
The aim of this study was to propose a methodology to investigate the tumour heterogeneity and evaluate its ability to pre-
dict pathologically complete response (pCR) after chemo-radiotherapy (CRT) in locally advanced rectal cancer (LARC). 
This approach consisted in normalising the pixel intensities of the tumour and identifying the different sub-regions using 
an intensity-based thresholding. The spatial organisation of these subpopulations was quantified using the fractal dimen-
sion (FD). This approach was implemented in a radiomic workflow and applied to 198 T2-weighted pre-treatment magnetic 
resonance (MR) images of LARC patients. Three types of features were extracted from the gross tumour volume (GTV): 
morphological, statistical and fractal features. Feature selection was performed using the Wilcoxon test and a logistic regres-
sion model was calculated to predict the pCR probability after CRT. The model was elaborated considering the patients 
treated in two institutions: Fondazione Policlinico Universitario “Agostino Gemelli” of Rome (173 cases, training set) and 
University Medical Centre of Maastricht (25 cases, validation set). The results obtained showed that the fractal parameters 
of the subpopulations have the highest performance in predicting pCR. The predictive model elaborated had an area under 
the curve (AUC) equal to 0.77 ± 0.07. The model reliability was confirmed by the validation set (AUC = 0.79 ± 0.09). This 
study suggests that the fractal analysis can play an important role in radiomics, providing valuable information not only 
about the GTV structure, but also about its inner subpopulations.
Keywords Radiomics · Fractals · Rectal cancer · Predictive model · Magnetic resonance imaging
Introduction
The use of biomedical imaging for diagnosis and therapy 
purposes in oncology has exponentially increased in the last 
few decades. The interpretation of these images is crucial to 
perform correct diagnosis and to choose the most appropri-
ate treatment for the patient [1].
Radiomics is an emerging discipline that aims to ana-
lyse biomedical imaging through a quantitative approach, 
allowing the detection of physio-pathological features of the 
healthy or tumour tissues that is not directly estimable by 
visual inspection [2, 3].
To date, radiomics has been applied to several tumours 
(lung, breast and prostate [4–6]) and for different diagnostic 
imaging techniques (computed tomography (CT), magnetic 
resonance (MR), and positron emission tomography (PET) 
[4, 7, 8]), showing promising results.
The high number of parameters extractable from digital 
images, together with clinical and pathological patient data, 
can be correlated with clinical outcomes to elaborate clinical 
decision support tools [9].
This work focused on the application of radiomics on 
MR images of patients affected by locally advanced rectal 
cancer (LARC).
The standard care for these patients is represented by neo-
adjuvant chemo radiation therapy (CRT) followed by total 
mesorectal excision (TME) [10, 11]. Approximately 11–42% 
of these patients show a pathological complete response 
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(pCR) after CRT; different studies demonstrated that patients 
showing pCR usually have a better prognosis in terms of 
local failure, metastases-free survival and overall survival 
[12, 13]. Recent studies have proposed more conservative 
surgical approaches, such as local excision or wait and see, 
to reduce morbidities related to TME in patients, in which 
complete response is observed [14, 15].
Elaborating predictive models that are able to identify 
which patients could result to be clinical complete respond-
ers therefore gained great importance for their correct mul-
tidisciplinary management.
The model developed in this investigation aims to predict 
the pCR probability analysing pre-treatment T2-weighted 
MR images. Magnetic Resonance Imaging (MRI) represents 
the gold standard in rectal cancer diagnosis, as it provides 
excellent soft tissue contrast and high spatial resolution [16].
Because of these characteristics, this imaging modal-
ity can describe with high precision the heterogeneity of 
the tumour, which is considered today as an important bio-
marker for response prediction. Recent studies have demon-
strated that tumour sensitivity to treatments could be linked 
to tumoral spatial organisation, which reflects its heterogene-
ous cellular population [17].
Fractal Analysis is considered a reliable method to quan-
tify the tumour heterogeneity [18]. Fractals are structures 
that display a repeating pattern at different size scales; this 
property is quantified by a parameter named fractal dimen-
sion that measures the self-similarity grade of the structure 
under analysis [19]. An image processing procedure that 
combines fractal and segmentation analysis has been pro-
posed to investigate cancer heterogeneity on MR images, 
similar to the approach described by Szigeti et al., for study-
ing lung tumour heterogeneity on mice CT scans [20].
We first identified different tumour subpopulations 
through an intensity-based segmentation applied on nor-
malised values and then their spatial organisation has been 
described using fractal dimensions. The aim of this study 
was to implement our fractal-based approach in a radi-
omic analysis to quantify the rectal cancer heterogeneity 
in patients affected by LARC and to elaborate a predictive 
model able to esteem the pCR probability of a patient by 
analysing the pre-treatment MR.
Materials and methods
Patients
This study was conducted on the pre-treatment MR images 
of the patients treated in two hospital centres: Fondazione 
Policlinico Universitario “Agostino Gemelli” (Rome, Italy) 
and MAASTRO Clinic (GROW, MUMC, Maastricht, the 
Netherlands).
Policlinico Gemelli retrospectively collected 173 patients 
among those treated between May 2008 and December 
2014. MAASTRO Clinic prospectively collected 25 patients 
considering the THUNDER trial (THeragnostic Utilities for 
Neoplastic DisEases of the Rectum, NCT 00969657).
The enrolled patients had a pathological diagnosis of 
LARC and they were older than 18 years, when the disease 
was diagnosed. All the patients signed informed consent 
for data collection and they were treated with neo-adjuvant 
chemo-radiotherapy followed by total mesorectal excision 
6–8 weeks after the end of CRT.
The pathological post-operative data included histology, 
grading and tumour regression grade (TRG) according to 
Mandard classification [21]. Pathological complete response 
was defined in case of ypT0N0 or ypN0/ypNx.
Image analysis
The MR images analysed were obtained following a pro-
tocol that considers T2-weighted fast spin-echo 2D images 
acquired in a plane orthogonal to the tumour longitudinal 
axis [16]. No intravenous contrast agents were administered. 
Further details about image acquisition parameters are avail-
able as supplementary material.
The MR images were then uploaded on a radiotherapy 
delineation console (Eclipse, Varian Medical System™, Palo 
Alto, California, USA) and the gross tumour volume (GTV) 
was delineated by a team of two radiation oncologists and 
two radiologist experts in rectal cancer, following the guide-
lines defined in ICRU n.83 [22].
The DICOM files containing the MR images and the cor-
responding RT Structure files were imported in Moddicom, 
an open source R (R Core Team, Vienna, Austria) package 
[23] developed by the KBO Labs of the Fondazione Policlin-
ico Universitario “Agostino Gemelli” to perform quantitative 
image analysis [24].
Figure 1 shows the image processing applied to each 
case to analyse tumour heterogeneity, studying the spatial 
organisation of the subpopulations inside it. It consisted of 
three steps:
Normalisation
Considering the pixel intensities P(x,y) of a determined 
GTV structure, they were normalised according to the fol-
lowing formula:
(1)N (x, y) =
P(x, y) −min[I (x, y)]
max[I (x, y)] −min[I (x, y)]
,
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where min[I(x,y)] and max[I(x,y)] are, respectively, the 1st 
and the 99th percentile of the grey-level histograms repre-
senting the GTV, to minimise the influence linked to the 
spike pixels.
Subpopulations identification
Different clusters were identified in the GTV slices con-
taining the normalised intensity values. The segmentation 
was automatically performed considering the pixels whose 
intensities were included between two threshold levels 
defined as percentages of the GTV maximum. Pixels with 
similar intensity levels were gathered and considered as 
new structures, here defined as “subpopulations”.
Fractal analysis
The spatial organisation of these subpopulations was quanti-
fied, calculating the fractal dimension of the border includ-
ing the analysed subpopulation.
The fractal dimension was calculated using the software 
developed in R and C environment implementing the box-
counting method. This procedure consisted in covering the 
image with fixed-side (d) squares and counting the number 
(N) of squares containing the image border. This process was 
then repeated with the change of the side square size. The 
Fig. 1  Schematic representation of the image processing, developed 
to analyse tumour heterogeneity in a patient. The original pixel values 
contained inside the GTV volume were normalised considering the 
1st and 99th percentile of the grey-level histograms. Different pixel 
clusters (subpopulations) were identified considering various inten-
sity thresholds. The box-counting method was applied slice by slice 
to estimate the fractal dimension of the subpopulations identified
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number of counts as a function of the side square was plot-
ted on a log–log graph and a linear fit is applied. The angular 
coefficient of the linear fit was an estimation of the fractal 
dimension [25].
This software was validated comparing its results with those 
obtained using the ImageJ software [26] on simple geometries 
with known fractal dimensions (line, square, Koch curve).
For each individuated subpopulation, the FD calculation 
was performed on all GTV slices; mean, median, maxi-
mum and minimum FD distribution values were considered 
as parameters representing the spatial organisation of the 
subpopulation.
Feature extraction
Three types of features were automatically calculated by 
means of Moddicom:
(1) Fractal features, considered as parameters quantifying 
the tumour heterogeneity.
(2) Morphological features, describing the tumour geom-
etry and GTV shape (surface and volume, surface/vol-
ume ratio, eccentricity).
(3) Statistical features, describing the behaviour of grey-
level histogram representing the GTV volume (entropy, 
skewness and kurtosis).
The statistical features were calculated applying the Lapla-
cian of Gaussian (LoG) filter to the raw images.
This filter consists of an implemented convolution kernel 
that applies the following equation to the original pixels:
where x and y represent the coordinates of pixels surround-
ing the central one (on which equation is used to calculate 
the convolution) and σ is the size of standard deviation in 
the LoG equation, expressed in mm [27].
This filter, adopted by Ng et al. [28]. on CT images of colo-
rectal cancer, was used to smooth the high-frequency noise of 
the images and enhance the variation of values among adjacent 
pixels. Different σ values were investigated, ranging from 0.2 
to 4 mm.
No filter was instead used on the subpopulations individu-
ated for the fractal analysis, according to the different works 
calculating FD on original images [29, 30].
Data analysis
All the extracted features were collected in a database and 
associated to the clinical TNM classification at diagnosis 














A predictive model was then elaborated having patients 
enrolled by the Policlinico Gemelli as training set (TS) and 
those from MAASTRO Clinic as validation set (VS).
The heterogeneity between the training and validation 
cohorts was evaluated in terms of Wilcoxon–Mann–Whit-
ney and Pearson’s χ2 test [31]. Highly relevant features were 
identified as a first step for data analysis using the Wilcoxon 
test method.
This test was recently addressed as the most reliable and 
accurate method for feature selection in radiomics by Par-
mar et al. [32], who compared 14 feature selection methods 
used in different radiomic studies. Features were considered 
significant, when p value was lower than 0.05. The features 
selected by this test were then collected in a cross-corre-
lation matrix, to identify and eliminate redundant features 
[31].
Many linear logistic regression models were elaborated 
to predict the binary outcome (pCR vs. no pCR) using the 
features that showed low mutual correlation values in the 
cross-correlation matrix (|R| < 0.3).
The best predictive model was selected using the Akaike 
information criteria [33].
The discrimination power of the final model was evalu-
ated in terms of Receiver Operating Characteristic (ROC) 
analysis, and an external validation was performed using the 
MAASTRO patients as validation set [34].
A nomogram was then produced for a visual representa-
tion of the predictive model.
Results
Table  1 summarises the clinical characteristics of the 
patients involved in this study. The statistical tests performed 
confirmed the heterogeneity of the cohorts adopted.
Pathologic complete response (TRG = 1) was reached 
in 47 patients of Rome (pCR occurrence rate equal to 27%) 
and in 7 patients of Maastricht (pCR occurrence rate equal 
to 28%). The proportions observed between positive and 
negative outcomes were consistent with clinical literature 
data [12].
The majority of the Rome patients (83.3%) had a pre-
scription dose of 55 Gy. The same dose has been prescribed 
to all the Maastricht patients. No significant relationship 
between radiotherapy dose and pCR probability has been 
observed.
Table 2 contains the results of the Wilcoxon test obtained 
for the fractal features; most of these features showed high 
significance in separating pCR and no pCR patient groups.
The median fractal dimension calculated on the GTV 
original contours (as manually delineated by the radiation 
oncologists) showed a p value equal to 0.008 (subpopulation 
0–100 in Table 2).
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The median FD evaluated for the 0–60 subpopulation and 
the maximum FD for the 40–100 and 50–100 subpopulations 
showed higher statistical significance (p value = 0.001) in 
identifying pCR patients in respect to median FD on the 
original GTV contours.
The morphological features did not show statistical sig-
nificance in separating pCR and no pCR patient groups.
For the statistical features, the highest significance was 
observed for entropy (p = 0.048) and skewness (p = 0.006), 
when the LoG filter was applied to MR images (σ = 0.34 mm 
for entropy, 0.48 mm for skewness).
The cross-correlation matrix containing the significant 
features is available in the supplementary material.
The fractal and statistical features were uncorrelated 
overall (maximum absolute correlation value |R| = 0.47, 
median absolute correlation value |R| = 0.21). Entropy 
and skewness showed |R| < 0.1 for all the sigma sizes of 
the applied LOG filter.
The best predictive model resulting from the Aikake 
analysis took into account two clinical features identified 
at diagnosis (cT and cN) and three parameters extracted 
from the MR staging images:
• The skewness calculated applying a LoG filter with 
σ = 0.48 mm;
• The entropy calculated applying a LoG filter with 
σ = 0.34 mm;
• The maximum FD calculated on the subpopulation con-
stituted by pixels with intensities between 40 and 100% 
of GTV maximum.
Table 1  Patient’s characteristics 
and descriptive statistics of 
variables in the cohort patients 
of Policlinico Gemelli (Rome, 
173 patients) and MAASTRO 
Clinic (Maastricht, 25 patients)
In the last few columns, the statistical tests to investigate the statistical significance are reported
χ2 test pearson’s χ2 test, MW test Mann–Whitney test, N number, cT clinical T stage, cN clinical N stage, 
TRG  = 1 pathological complete response, TRG  > 1 pathological not complete response, RT radiotherapy, 
CT chemotherapy
Rome Maastricht p values for differences
Patient’s characteristics
Age Statistic test
Mean Range Mean Range χ2 test MW test
Sex
 Male 64 28–84 63.3 52–80 – 0.573
 Female 61.9 43–80 63.8 47–73 – 0.698
Age 63.0 28–84 63.5 47–80 – 0.878
Clinical features
N % N % χ2 test MW test
Stage
 cT
  2 15 8.7 1 4 1.105 –
  3 100 57.8 20 80
  4 58 33.5 4 16
 cN
  0 10 5.8 3 12 0.455 –
  1 60 34.7 7 28
  2 103 59.5 15 60
Response
 TRG = 1 47 27 7 28 1.000 –
 TRG > 1 126 73 18 72
RT dose
 < 50.4 7 4 – – – –
 50.4 19 11 – – – –
 55 144 83.3 25 100 – –
 > 55 3 1.7 – – – –
Concurrent CT
 Yes 169 97.7 25 100 – –
 No 4 2.3 – – – –
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The values of the parameters and coefficients charac-
terizing the model are reported in Table 3.
Figure 2 shows the ROC curves of the model developed 
on training (left) and validation set (right); the AUC val-
ues obtained were 0.775 and 0.790, respectively.
Figure  3 shows a nomogram of the model, which 
includes all the considered covariates.
Discussion
Radiomics in MRI: difficulties and opportunities
The application of radiomics to MRI had minor diffusion 
in comparison to CT and PET applications, even if MRI 
today represents the most accurate imaging technique for 
soft tissues.
This limited diffusion is correlated to the high complex-
ity of the MR images process and standardization. Signal 
intensity can indeed be highly variable in these images, 
as it results from a complex interplay of different factors, 
joining tissue properties (such as relaxation time), patient 
specific characteristics and technical scan acquisition 
parameters [3].
Although several methods have been proposed to over-
come the standardization problem (such as histogram 
matching or normalisation to an external ROI signal), the 
individuation of a common strategy is still far [35].
McGarry et al. [7] have recently proposed a strategy to 
normalise the MR signal in brain, dividing each voxel inten-
sity by the standard deviation of the whole brain signal.
This methodology was applied to the MR images of 
81 glioblastoma patients and a predictive model was then 
proposed to identify patients with poor prognosis at the 
time of tumour diagnosis. In particular, the authors quanti-
fied tumour heterogeneity, creating different radiomic pro-
files originating from the combination of the information 
extracted from four different MR contrasts.
In this investigation, we presented a new approach to 
process the MR signal, consisting in the normalisation of 
each pixel inside the GTV in reference to the 1st and 99th 
percentile of the overall GTV intensity level histogram, 
to eliminate spike signals and focus on the informative 
content of the analysed GTV.
Potentialities of fractal analysis in radiomics
After the normalisation, we evaluated the tumour heteroge-
neity analysing the spatial organisation of the pixel clusters 
with common intensities by means of fractal dimensions, as 
performed by Szigeti et al., on lung cancer CT images [20].
The results obtained in the feature selection process 
showed that the fractal parameters related to tumour sub-
populations have higher performance in predicting pCR 
than statistical and morphological features.
The high informative content of the fractal dimension 
was also confirmed in the elaboration of the predictive 
model, where the maximum FD of the subpopulation with 
pixel intensity higher than 40% appeared to be the most 
significant parameter of the model.
Table 2  p values obtained by applying the Wilcoxon–Mann–Whitney 
test to evaluate pCR prediction ability for the different fractal features 
investigated to varying the subpopulations
Threshold Mean FD Median FD Min FD Max FD
0–20 0,405 0.333 0.625 0.051
0–40 0.003 0.002 0.152 0.004
0–60 0.001 0.002 0.022 0.003
0–80 0.002 0.004 0.017 0.078
0–100 0.008 0.008 0.100 0.160
10–30 0.061 0.068 0.408 0.019
10–50 0.008 0.006 0.150 0.016
10–70 0.022 0.014 0.374 0.040
20–40 0.043 0.023 0.460 0.023
20–60 0.032 0.018 0.261 0.042
20–80 0.066 0.037 0.516 0.029
30–50 0.025 0.017 0.805 0.009
30–70 0.035 0.017 0.944 0.003
30–90 0.030 0.012 0.794 0.010
40–60 0.011 0.011 0.490 0.006
40–80 0.012 0.015 0.306 0.003
30–100 0.034 0.017 0.923 0.012
40–100 0.011 0.010 0.487 0.001
50–100 0.007 0.015 0.236 0.001
60–100 0.014 0.022 0.268 0.006
70–100 0.129 0.092 0.572 0.154
Table 3  Covariates and coefficients of the linear logistic regression 
model elaborated to predict pCR starting from the analysis of T2 
weighted staging MR images
Covariate Coefficient σ (coefficient) p value
Intercept 11.366 6.119 0.063
 cT − 0.997 0.3772 0.007
 cN 0.619 0.359 0.084
Skewness (σ = 0.48 mm) − 3.601 1.361 0.008
Entropy (σ = 0.34 mm) 2.948 1.719 0.086
Max FD (40–100) − 9.862 3.228 0.002
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Fig. 2  ROC curves and AUC values representing the performance of the predictive model elaborated calculated for the training (left) and valida-
tion set (right)
Fig. 3  Nomogram of the predictive model developed
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The proposed statistical model predicts with high accu-
racy (AUC = 0.78 in training set and 0.80 in validation 
set) whether pCR will be obtained for a specific patient, 
starting from the analysis of the staging MR.
A predictive model for pCR starting from 18FDG 
PET–CT images was recently proposed by van Stiphout 
et al. [36]. The model, elaborated on 190 patients, showed 
predictive performances comparable to our model in 
training set (AUC = 0.78) but lower in the validation set 
(AUC = 0.70).
In 2015, Intven et al. [37] proposed a model to evaluate 
treatment response after CRT in LARC patients, by analys-
ing different MR sequences (T2w volumetry, DW-MRI and 
DCE-MRI) acquired before and after CRT. In their explora-
tive study (55 analysed patients), they observed that a sig-
nificant increase in the apparent diffusion coefficient (ADC) 
after CRT was correlated to non-responder patients.
One of the most significant advantages offered by our 
model is represented by the fact that only MR images 
acquired before treatment are required to calculate the pCR 
probability. In this way, the model can be useful in clinical 
practice to evaluate the best chemo-radiotherapy treatment 
to offer to the specific patient, moving towards a vision of 
personalised medicine.
New frontiers in fractal‑based radiomics
One of the limitations of our model is that the fractal analy-
sis was performed only in 2D modality; this choice is linked 
to the different pixel resolutions between the planar image 
and the slice thickness.
The implementation of 3D fractal analysis, by means of 
interpolation algorithms and mesh-based approaches, would 
be interested to investigate the self-similarity of the entire 
disease volume.
However, the fact that a parameter as the maximum FD, 
related to a single tumour slice and obtained by a 2D analy-
sis, provides the most valuable information in the predictive 
model reflects the idea that the overall tumour aggressive-
ness can be determined by the characteristics of a single part 
of the disease.
In particular, we observed that a higher FD value is pre-
dictive of a lower pCR probability, as it reflects a more com-
plex and compact tumour structure (as shown in Fig. 4).
This effect could be explained, supposing that pixels with 
intensity higher than 40% correspond to the areas of the 
tumour with a specific metabolic hallmark (e.g., hypoxia). 
Further studies are required to verify this or other interest-
ing hypotheses at a cellular level (e.g., angiogenesis, vascu-
larization, receptor expression), by comparing MR images 
with pathological specimen data and imaging biomarkers 
information.
Conclusion
The possibility to provide spatial information related to 
tumour sub-regions can furthermore open important sce-
narios in biophysics and radiotherapy planning. In fact, 
assuming that the pixel clusters with shared intensity 
levels correspond to cell groups with individual physi-
cal and radiobiological characteristics, the possibility to 
detect these clusters could allow dose modulation within 
the tumour through dose-painting protocols.
In conclusion, the method proposed in this work is able 
to detect from MR images, valuable information about the 
rectal tumour heterogeneity, to predict the pCR probability 
after CRT in case of LARC patients.
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